MEDICINE

Even in the best-case scenario, the experts said, people will continue to die of COVID-19.

Bundesliga restart blow as three test positive for coronavirus at Cologne

A ventilator set too high by medical resident doctors may have caused the death of a coronavirus patient in New York, according to reports.

Memories of smallpox outbreak stir nostalgia for Tito's time

Scientists worldwide are set to break records to develop a vaccine for COVID-19.

Pfizer eyes 10-20 mn doses of experimental COVID-19 vaccine by year-end

Scientists found that inflammation may be added to the list of symptoms of coronavirus.

Sun, sand and social distancing: Spain seeks tourism revival

The mother reportedly had bruises on her neck and the baby had them on the side of his face and the back of his hand.

Epidemiologists say it takes at least 10 years, on average, to develop, test and produce a new anti-viral vaccine.

Only one customer will be served at the restaurant each day.

This might be a possible reason as to why many COVID-19 recovered patients discharged from hospitals test positive again.

Rare inflammatory syndrome seen in children with COVID-19

As the race for vaccines against the deadly novel coronavirus continues, researchers use 8 different approaches to come up with the best way to fight COVID-19.

A report revealed that an arthritis drug might provide clinical benefit to coronavirus patients considered to be seriously ill.

Antibody tests showing whether a person has recovered from COVID-19 infection are being rolled out to care offices across New York, The Post reported.

Social distancing appeared to have been ignored at the New York Metro area Tuesday as hundreds of residents stood shoulder-to-shoulder to watch Thunderbirds and Blue Angels roar across the sky.

DARPA is working on a "temporary vaccine" that would serve as a "firebreak" that would provide immunity for several months until a regular vaccine is made available. The researchers used two different methods to manufacture and clone the most potent antibodies of coronavirus patient survivors. The temporary treatment would provide protection to frontline workers and first responders to COVID-19 hotspots. The researchers have invested in technology that would shorten the process from several years to only several weeks and they plan to hold clinical trials in the summer.

Dr. Anthony Fauci of the National Institute of Allergy and Infectious Diseases seemed to confirm this, warning a possible resurgence of the coronavirus next year.

Reverend Michael Way originally planned to deliver the sacrament via telephone.

Airborne traces of the virus in the room where health workers remove their protective equipment was no longer detected after sanitation procedures.